Target Binding Site Detail
Target General Information | Top | ||||
---|---|---|---|---|---|
Target ID | T83904 | Target Info | |||
Target Name | NAD-dependent deacetylase sirtuin-2 (SIRT2) | ||||
Synonyms | SIR2like protein 2; SIR2L2; SIR2L; SIR2-like protein 2; Regulatory protein SIR2 homolog 2; NADdependent protein deacetylase sirtuin2; NAD-dependent protein deacetylase sirtuin-2 | ||||
Target Type | Patented-recorded Target | ||||
Gene Name | SIRT2 | ||||
Biochemical Class | Carbon-nitrogen hydrolase | ||||
UniProt ID |
Ligand General Information | Top | ||||
---|---|---|---|---|---|
Ligand Name | Carba-Nicotinamide-Adenine-Dinucleotide | Ligand Info | |||
Canonical SMILES | C1C(C(C(C1[N+]2=CC=CC(=C2)C(=O)N)O)O)COP(=O)(O)OP(=O)(O)OCC3C(C(C(O3)N4C=NC5=C(N=CN=C54)N)O)O | ||||
InChI | 1S/C22H29N7O13P2/c23-19-14-21(26-8-25-19)29(9-27-14)22-18(33)17(32)13(41-22)7-40-44(37,38)42-43(35,36)39-6-11-4-12(16(31)15(11)30)28-3-1-2-10(5-28)20(24)34/h1-3,5,8-9,11-13,15-18,22,30-33H,4,6-7H2,(H5-,23,24,25,26,34,35,36,37,38)/p+1/t11-,12-,13-,15-,16+,17-,18-,22-/m1/s1 | ||||
InChIKey | DGPLSUKWXXSBCU-VGXGLJSLSA-O | ||||
PubChem Compound ID | 163884 |
Drug Binding Sites of Target | Top | |||||
---|---|---|---|---|---|---|
PDB ID: 5G4C Human SIRT2 catalyse short chain fatty acyl lysine | ||||||
Method | X-ray diffraction | Resolution | 2.10 Å | Mutation | No | [1] |
PDB Sequence |
QKERLLDELT
63 LEGVARYMQS73 ERCRRVICLV83 GAGISTSAGI93 PDFRSPTGLY104 DNLEKYHLPY 114 PEAIFEISYF124 KKHPEPFFAL134 AKELYPGQFK144 PTICHYFMRL154 LKDKGLLLRC 164 YTQNIDTLER174 IAGLEQEDLV184 EAHGTFYTSH194 CVSASCRHEY204 PLSWMKEKIF 214 SEVTPKCEDC224 QSLVKPDIVF234 FGESLPARFF244 SCMQSDFLKV254 DLLLVMGTSL 264 QVQPFASLIS274 KAPLSTPRLL284 INKEKAGQGG306 MDFDSKKAYR316 DVAWLGECDQ 326 GCLALAELLG336 WKKELEDLVR346 REHASIDAQ
|
|||||
|
GLY84
3.212
ALA85
2.712
GLY86
3.317
SER88
3.729
THR89
2.871
SER90
4.794
ILE93
3.763
PRO94
2.976
ASP95
3.281
PHE96
2.873
ARG97
2.879
SER98
3.932
LEU103
4.243
GLN167
2.557
ASN168
3.327
ILE169
2.816
|
|||||
PDB ID: 4X3P Sirt2 in complex with a myristoyl peptide | ||||||
Method | X-ray diffraction | Resolution | 1.80 Å | Mutation | No | [2] |
PDB Sequence |
GSQKERLLDE
61 LTLEGVARYM71 QSERCRRVIC81 LVGAGISTSA91 GIPDFRSPST101 GLYDNLEKYH 111 LPYPEAIFEI121 SYFKKHPEPF131 FALAKELYPG141 QFKPTICHYF151 MRLLKDKGLL 161 LRCYTQNIDT171 LERIAGLEQE181 DLVEAHGTFY191 TSHCVSASCR201 HEYPLSWMKE 211 KIFSEVTPKC221 EDCQSLVKPD231 IVFFGESLPA241 RFFSCMQSDF251 LKVDLLLVMG 261 TSLQVQPFAS271 LISKAPLSTP281 RLLINKEKAG291 QSDPFLGGMD308 FDSKKAYRDV 318 AWLGECDQGC328 LALAELLGWK338 KELEDLVRRE348 HASIDAQ
|
|||||
|
GLY84
3.302
ALA85
2.673
GLY86
3.239
SER88
3.868
THR89
2.838
SER90
4.858
ILE93
3.703
PRO94
3.095
ASP95
3.215
PHE96
2.917
ARG97
2.878
SER98
3.799
LEU103
4.376
GLN167
2.659
ASN168
3.306
ILE169
2.825
|
References | Top | ||||
---|---|---|---|---|---|
REF 1 | SIRT2 Reverses 4-Oxononanoyl Lysine Modification on Histones. J Am Chem Soc. 2016 Sep 28;138(38):12304-7. | ||||
REF 2 | Deacylation Mechanism by SIRT2 Revealed in the 1'-SH-2'-O-Myristoyl Intermediate Structure. Cell Chem Biol. 2017 Mar 16;24(3):339-345. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.